MAPK1 and melanoma: Other researchers have found that tangeretin can promote the production of melanin in melanoma cells and can induce hyperpigmentation by activating melanin production signaling proteins and initiating sustained ERK2 expression; therefore, it has therapeutic potential for the treatment of melanoma and melanoma-related pigmentation loss [65].